Epigenetic regulation in cancer therapy: From mechanisms to clinical advances
MedComm – Oncology · 2024-03 · 3 (1)
DOI: 10.1002/mog2.59 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm – Oncology, online erschienen am 04.01.2024. Verfasst von Lei Tao und 13 weiteren Autor:innen. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 494 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, West China Hospital, Sichuan University.
Abstract (Originalsprache)
Epigenetic regulation refers to the alteration of gene expression independent of changes in DNA sequence. It involves chemical modifications such as DNA methylation, histone methylation, and histone acetylation, which are regulated by a coordinated interplay of various regulators to ensure precise spatial and temporal regulation of gene expression. Epigenetic aberrations are commonly observed in cancer and are considered as hallmarks of cancer. In recent years, small molecules targeting specific epigenetic regulators have been developed and are demonstrating promising therapeutic potential in preclinical and clinical trials for cancer treatment. In this review, we summarize the essential regulatory mechanisms and dysfunctions of epigenetic regulators involved in DNA methylation, histone methylation, and histone acetylation during tumor development and progression. Moreover, we discuss the current advances and challenges in cancer epigenetic therapy that target these mechanisms in both hematologic malignancies and solid tumors. Finally, we discuss the potential of combining epigenetic drugs with other therapies, including chemotherapy, radiotherapy, targeted therapy, and immunotherapy, as a promising approach for cancer treatment. Overall, we aim to enhance the understanding of epigenetic regulation in cancer therapy and explore targeted therapeutic strategies based on these mechanisms, to ultimately advance cancer therapy and improve patient prognosis.
Förderung
- National Natural Science Foundation of China
- West China Hospital, Sichuan University
Zitieren
APA
Tao, L., Zhou, Y., Luo, Y., Qiu, J., Xiao, Y., Zou, J., Zhang, Y., Liu, X., Yang, X., Gou, K., Xu, J., Guan, X., Cen, X., & Zhao, Y. (2024). Epigenetic regulation in cancer therapy: From mechanisms to clinical advances. MedComm – Oncology, 3(1). https://doi.org/10.1002/mog2.59
Vancouver
Tao L, Zhou Y, Luo Y, Qiu J, Xiao Y, Zou J, et al. Epigenetic regulation in cancer therapy: From mechanisms to clinical advances. MedComm – Oncology. 2024;3(1). doi:10.1002/mog2.59
BibTeX
@article{Tao2024,
author = {Tao, Lei and Zhou, Yue and Luo, Yuan and Qiu, Jiahao and Xiao, Yuzhou and Zou, Jiao and Zhang, Yu and Liu, Xingchen and Yang, Xinyu and Gou, Kun and Xu, Jing and Guan, Xinqi and Cen, Xiaobo and Zhao, Yinglan},
title = {Epigenetic regulation in cancer therapy: From mechanisms to clinical advances},
journal = {MedComm – Oncology},
year = {2024},
volume = {3},
number = {1},
doi = {10.1002/mog2.59}
}
EUVIMED